Moreover, the success of lipid nanoparticles (LNP)-formulated siRNA targeting VEGF and kinesin spindle protein (KSP) in cancer patients with liver metastasis raised a hope that silencing SIX1 expression using shRNA or miRNA maybe a potential cancer treatment strategy (34). Here, SIX1 is linked to cancer.